605177 logo

Zhejiang East Asia Pharmaceutical Co., Ltd. Stock Price

SHSE:605177 Community·CN¥2.3b Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 0 Fair Values set on narratives written by author

605177 Share Price Performance

CN¥0
-18.30 (-100.00%)
CN¥0
-18.30 (-100.00%)
Price CN¥0

605177 Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Mediocre balance sheet and slightly overvalued.

1 Risk
0 Rewards

Zhejiang East Asia Pharmaceutical Co., Ltd. Key Details

CN¥831.6m

Revenue

CN¥742.3m

Cost of Revenue

CN¥89.2m

Gross Profit

CN¥307.5m

Other Expenses

-CN¥218.2m

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Apr 23, 2026
-1.94
10.73%
-26.24%
54.3%
View Full Analysis

About 605177

Founded
1998
Employees
1749
CEO
Cheng Chi
WebsiteView website
www.eapharm.cn

Zhejiang East Asia Pharmaceutical Co., Ltd. produces and sells pharmaceutical chemicals, tablets, granules, intermediates, and capsules. It offers quinolones synthetic antibacterial agents, antifungal products, gastrointestinal medications, semi-synthetic cephalosporin antibiotics, carbapenem antibiotics, antiviral agents, central nervous system medications, respiratory drugs, antiallergic agents, antineoplastic agents and tumor adjuvant drugs, and other products. The company provides products in the fields of cardiovascular, anti-aging dementia, digestive system, diabetic neuropathy, and anti-pathogenic microorganisms. It serves customers through a sales network in Japan, South Korea, Europe, America, Southeast Asia, and internationally. Zhejiang East Asia Pharmaceutical Co., Ltd. was founded in 1998 and is headquartered in Taizhou, China.

Recent 605177 News & Updates

Recent updates

No updates